Research Analysts’ Weekly Ratings Updates for Draegerwerk AG & Co KGaA (DRW3)

Draegerwerk AG & Co KGaA (ETR: DRW3) has recently received a number of price target changes and ratings updates:

  • 7/17/2017 – Draegerwerk AG & Co KGaA was given a new €85.00 ($98.84) price target on by analysts at Independent Research GmbH. They now have a “sell” rating on the stock.
  • 7/14/2017 – Draegerwerk AG & Co KGaA was given a new €114.00 ($132.56) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 7/14/2017 – Draegerwerk AG & Co KGaA was given a new €96.00 ($111.63) price target on by analysts at Warburg Research. They now have a “neutral” rating on the stock.
  • 7/11/2017 – Draegerwerk AG & Co KGaA was given a new €93.00 ($108.14) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 7/5/2017 – Draegerwerk AG & Co KGaA was given a new €91.00 ($105.81) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.

Draegerwerk AG & Co KGaA (ETR DRW3) opened at 94.05 on Tuesday. Draegerwerk AG & Co KGaA has a 12-month low of €56.68 and a 12-month high of €107.63. The firm has a market cap of €1.67 billion and a PE ratio of 27.45. The stock’s 50 day moving average price is €96.41 and its 200-day moving average price is €92.65.

Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The Company operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care.

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply